Novartis appoints head of Russian operations
This article was originally published in Scrip
Vadim Vlasov has been appointed president of Novartis's business in Russia, he succeeds Altan Demirdere. Mr Vlasov was formerly head of Russian offices of aviation companies EADS and Airbus, and he will remain on the board of Irkut, the Russian aircraft manufacturer in his new post.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.